Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor page or CMS update. This change does not modify the study details, enrollment information, or outcomes.
    Difference
    0.1%
    Check dated 2026-06-05T21:44:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study record now shows termination and posted results, with details on efficacy by RECIST v1.1 and linked documentation (PDF of the study protocol and statistical analysis plan) to support the results.
    Difference
    3%
    Check dated 2026-05-22T16:16:23.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision stamp v3.5.4 was added, replacing v3.5.3, reflecting a latest update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-05-15T14:27:12.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Updated the site’s displayed release/revision identifier from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:58.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Deleted Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:41.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.